Redsense Medical Q2 FY26 EBIT swings to profit of SEK 377,000; net sales rise 13% to SEK 7.09 million

• Redsense Medical posted Q2 net sales of SEK 7.09 million, up 12.97% year on year.
• EBIT returned to profit at SEK 377,000 from an operating loss of SEK 1.83 million a year earlier.
• Net profit swung to SEK 421,000; earnings per share turned positive at SEK 0.03.
• Sensor patch sales climbed to about 100,800 from 80,200, while U.S. partner alarm sales to end customers stayed broadly stable.
• Management cited inventory pre-funding and a SEK 5.56 million receivable paid in July; cash on hand was about SEK 13.5 million on Aug. 14.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redsense Medical AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 202608190230BITN____UKPR__EN_20260819-BIT-9333-0) on August 19, 2026, and is solely responsible for the information contained therein.